Strides Pharma Science reports consolidated net loss of Rs 121.67 crore in the December 2021 quarter

Sales decline 4.52% to Rs 794.39 crore

Net loss of Strides Pharma Science reported to Rs 121.67 crore in the quarter ended December 2021 as against net profit of Rs 37.85 crore during the previous quarter ended December 2020. Sales declined 4.52% to Rs 794.39 crore in the quarter ended December 2021 as against Rs 832.02 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales794.39832.02 -5 OPM %-2.8616.07 -PBDT-54.81112.21 PL PBT-115.7159.70 PL NP-121.6737.85 PL

Powered by Capital Market - Live News